BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34120185)

  • 1. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
    Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.
    Nicolaides AN; Griffin M; Panayiotou AG; Tyllis T; Bond D; Georgiou N; Kyriacou E; Avraamides C; Martin RM
    Int Angiol; 2022 Dec; 41(6):492-499. PubMed ID: 36285529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
    Matsushita K; Kaptoge S; Hageman SHJ; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JAN; Di Angelantonio E; Visseren FLJ; Pennells L; Coresh J
    Eur J Prev Cardiol; 2023 Jan; 30(1):8-16. PubMed ID: 35972749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the European SCORE2 models in a Canadian primary care cohort.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Khera R; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur J Prev Cardiol; 2024 Apr; 31(6):668-676. PubMed ID: 37946603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
    Østergaard HB; Hageman SHJ; Read SH; Taylor O; Pennells L; Kaptoge S; Petitjean C; Xu Z; Shi F; McEvoy JW; Herrington W; Visseren FLJ; Wood A; Eliasson B; Sattar N; Wild S; Di Angelantonio E; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Jan; 30(1):61-69. PubMed ID: 36208182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
    Mulas O; Abruzzese E; Luciano L; Iurlo A; Attolico I; Castagnetti F; Galimberti S; Bonifacio M; Annunziata M; Gozzini A; Orlandi EM; Stagno F; Binotto G; Pregno P; Fozza C; Loi M; Trawinska MM; De Gregorio F; Cattaneo D; Albano F; Iezza M; Baratè C; Scaffidi L; Elena C; Giai V; Scalzulli E; Breccia M; La Nasa G; Caocci G
    Ann Hematol; 2024 Feb; 103(2):427-436. PubMed ID: 38012435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study.
    Kist JM; Vos RC; Mairuhu ATA; Struijs JN; van Peet PG; Vos HMM; van Os HJA; Beishuizen ED; Sijpkens YWJ; Faiq MA; Numans ME; Groenwold RHH
    EClinicalMedicine; 2023 Mar; 57():101862. PubMed ID: 36864978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
    WHO CVD Risk Chart Working Group
    Lancet Glob Health; 2019 Oct; 7(10):e1332-e1345. PubMed ID: 31488387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Way to "SCORE" Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines.
    Graham IM; Di Angelantonio E; Huculeci R;
    Curr Cardiol Rep; 2022 Nov; 24(11):1679-1684. PubMed ID: 36441402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    LIFE-CVD2 Working Group
    Eur J Prev Cardiol; 2024 May; ():. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.
    Fox ER; Samdarshi TE; Musani SK; Pencina MJ; Sung JH; Bertoni AG; Xanthakis V; Balfour PC; Shreenivas SS; Covington C; Liebson PR; Sarpong DF; Butler KR; Mosley TH; Rosamond WD; Folsom AR; Herrington DM; Vasan RS; Taylor HA
    JAMA Cardiol; 2016 Apr; 1(1):15-25. PubMed ID: 27437649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations.
    Landolfo M; Allevi M; Spannella F; Giulietti F; Gezzi A; Sarzani R
    High Blood Press Cardiovasc Prev; 2023 Nov; 30(6):551-560. PubMed ID: 37902917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Disease Risk Scores and Incident Dementia and Cognitive Decline in Older Men and Women.
    Vishwanath S; Hopper I; Chowdhury E; Wolfe R; Freak-Poli R; Reid CM; Tonkin AM; Murray AM; Shah RC; Chong TT; Woods RL; McNeil J; Orchard SG; Nelson MR; Steves CJ; Ryan J
    Gerontology; 2024; 70(2):143-154. PubMed ID: 37984339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.